Polymers and Macromolecules

  • A. T. Florence
  • D. Attwood
Chapter

Abstract

This survey of the pharmaceutical aspects of polymers and macromolecules emphasises their use as formulation aids. It stresses the key features of polymers – their molecular weight distribution and their versatility in terms of their morphology, crystallinity, solubility and performance. It is convenient to think of polymeric systems as either water-soluble or waterinsoluble (this division, while not rigid as some polymers are water-dispersible, is useful in that it separates the two main areas of use which form the basis of this chapter). Water-soluble materials are used to modify the viscosity of aqueous solutions and to maintain the stability of suspensions, to form the basis of film coatings and as the basis of water-soluble matrices (for example, the polyoxyethylene glycols as suppository bases). Water-insoluble materials form membranes and matrices: the factors affecting the transport of drugs in the systems should be monitored – the thickness of the membrane, the solubility of the drug in the membrane and the relationship of this to its lipophilicity generally, copolymer ratios, porosity and heterogeneity of the mix caused by fillers or plasticisers.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. W. Billmeyer. Textbook of Polymer Science, 2nd edn, Wiley, New York, 1971Google Scholar
  2. 2.
    D. A. Tomalin. Scientific American 272(5), 62 (1995)Google Scholar
  3. 3.
    J. G. Pritchard. Poly( vinyl alcohol): Basic Properties and Uses, Macdonald, London, 1970Google Scholar
  4. 4.
    A. G. Mattha. Pharm. Acta Helv. 52, 233 (1977)PubMedGoogle Scholar
  5. 5.
    W. P. T. James et al. Lancet i, 638 (1978)CrossRefGoogle Scholar
  6. 6.
    N. A. Peppas and A. R. Khare. Adv. Drug Del. Rev. 11, 1 (1993)CrossRefGoogle Scholar
  7. 7.
    R. Wasicky. Planta Med. 9, 232 (1967)CrossRefGoogle Scholar
  8. 8.
    S. Weidenfeld et al. Diabetes 17,766 (1968)CrossRefGoogle Scholar
  9. 9.
    M. Wales, et al. J. Polymer Sci. 10, 279 (1953)CrossRefGoogle Scholar
  10. 10.
    H. L. Liveson, C-M. Lehr et al. J. Control. Rei. 29, 329, (1994)CrossRefGoogle Scholar
  11. 11.
    T. D. Turner. Pharm. J. 228, 206 (1982)Google Scholar
  12. 12.
    J. A. Myers. Pharm. J. 235, 270 (1985)Google Scholar
  13. 13.
    S. Aiba, N. Minoura et al. Biomaterials 6, 290 (1986)CrossRefGoogle Scholar
  14. 14.
    B. J. Munden, H. G. De Kay and G. S. Banker. J. Pharm. Sci. 53, 395 (1964)CrossRefPubMedGoogle Scholar
  15. 15.
    R. Jani, O. Gan, R. Rodstrom and S. Hancock. J. Ocular Pharmacal. 10, 57 (1994)CrossRefGoogle Scholar
  16. 16.
    T. Higuchi. J. Pharm. Sci. 52, 1145 (1963)CrossRefPubMedGoogle Scholar
  17. 17.
    C. Santis and R. W. Baker. J. Control. Rei. 35, 1 (1995)CrossRefGoogle Scholar
  18. 18.
    F. Theeuwes, D. R. Swanson et al. Br. J. Clin. Pharmacal. 19, 699 (1985)CrossRefGoogle Scholar
  19. 19.
    M. Wolff et al. Pharm. Res. 2, 23 (1985)CrossRefPubMedGoogle Scholar

Copyright information

© A. T. Florence and D. Attwood 1998

Authors and Affiliations

  • A. T. Florence
    • 1
  • D. Attwood
    • 2
  1. 1.The School of PharmacyUniversity of LondonUK
  2. 2.School of Pharmacy and Pharmaceutical SciencesUniversity of ManchesterUK

Personalised recommendations